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Summary
Background: We investigated an outbreak of community-acquired methicillin-resistant Staphy-
lococcus aureus (MRSA) infections that occurred among healthcare workers (HCWs) but not among
residents of a long-term care facility (LTCF).
Methods: Cases of S. aureus infection were sought by reviewing the medical records of residents
and HCWs. In order to identify risk factors for the development of an S. aureus infection, an
unmatched case—control study was conducted. Cases were all HCWs with a clinically compatible
S. aureus infection; controls were HCWs with no history of a clinically compatible S. aureus
infection. Cases and controls were interviewed and anterior nasal swabs were collected.
Results: Over a period of 14 months, a total of eight cases were identified among practice nurses,
giving an attack rate of 10% for this category of profession. All isolates were identified as MRSA
Panton—Valentine leukocidin (PVL)-producing SCCmec type IV. By multivariate analysis, working
in a specific zone and being a practice nurse were found to be statistically significant risk factors
for infection.
Conclusions: The current outbreak indicates that HCWsmay serve as vehicles for the entry of PVL-
positive MRSA strains from the community into LTCFs, and that deficient hygiene practices and
unrecognized carriagemay facilitate spread. Given the increasing prevalence of PVL-positiveMRSA
infections worldwide, guidelines for the eradication of PVL-positive MRSA carriage within closed
communities should be established and efforts to obtain cultures fromcompatible infections should
be made.
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During the last decade, community-acquired (CA) methicillin-
resistant Staphylococcus aureus (MRSA) infections among
young persons without healthcare-associated (HCA) risk fac-
tors have emerged worldwide and are becoming prevalent in
several communities. These infections are caused by strains
that almost exclusively carry the staphylococcal cassette
chromosome (SCC) mec type IV and the Panton—Valentine
leukocidin (PVL) genes and, unlike HCA-MRSA strains, are
not multi-resistant. Most infections caused by PVL-producing
MRSA strains are mild skin or soft tissue infections, however
severe life-threatening cases of necrotizing pneumonia and
sepsis have been reported.1 Outbreaks of CA-MRSA have been
reported in wrestling and football teams, daycare centers,
institutionalized adults with developmental disabilities, mili-
tary recruits, jail inmates, and men who have sex with
men.2—10 There are recent reports of transmission and out-
breaks of CA-MRSA infectionswithin healthcare facilities.11—16
In Greece, from June 2005 and following reports of high
rates of CA-MRSA in children,9 CA-MRSA infections became
officially notifiable to the Hellenic Center for Disease Control
and Prevention (HCDCP). In November 2007 we were notified
of a cluster of skin infections that had occurred among
healthcare workers (HCWs) working in a long-term care
facility (LTCF) in Athens. We describe herein the investiga-
tions and interventions that occurred during this outbreak.
Methods
Setting
The outbreak occurred in a LTCF that provides care to
handicapped patients, mostly of advanced age. At the time
of notification (November 2007), there were 228 residents
cared for by 209 HCWs. Residents were distributed across
four zones (zones A to D). Practice nurses, cleaners,
and waiters were assigned to one zone. Physicians, nurses,
and administrative and technical personnel worked in all
zones.
Epidemiologic investigation
Cases of S. aureus infection were sought by reviewing the
medical records of residents and HCWs following receipt of
ethical permission. Microbiological confirmation in cases was
not sought before our visit, thus a case of S. aureus infection
was defined as a clinical skin or soft tissue infection compa-
tible with S. aureus infection.
In order to identify risk factors for the development of an
S. aureus infection, an unmatched case—control study was
conducted. Cases were all HCWs with a clinically compatible
S. aureus infection. Controls were HCWs with no history of
clinically compatible S. aureus infection. The list of controls
was generated by systematically selecting one in every five
HCWs from an alphabetical list. Forty-one HCWs were
selected as controls, of whom 36 agreed to participate. Cases
and controls were interviewed. The data shown in Table 1
were collected. Poor personal hygiene was defined as sharing
clothes or towels with other HCWs, hand-washing with plain
soap, not using liquid antiseptic for hand-washing, and/orpoor hygiene while using the toilet facilities (e.g., sitting
directly on the basins without using a disinfectant or a
waterproof paper). Informed consent was obtained from
all participants. The work was approved by the HCDCP.
Microbiologic investigation
During the investigation, clinical specimens were taken from
one HCW with an active infection. Anterior nasal swabs were
collected from all cases and controls and from 30 randomly
selected residents. Environmental cultures from surfaces
were sampled with moistened cotton swabs. Swabs were
inoculated in mannitol salt agar plates and examined at
48 h. S. aureus isolates were screened for oxacillin suscept-
ibility by the standard disk diffusion method.17 Detection of
themecA gene and SCCmec typing were performed by PCR.18
PVL determinants were detected by PCR.19 SmaI restriction
fragments of genomic DNAwere separated by pulsed field gel
electrophoresis (PFGE).20
Statistical analysis
Statistical analysis was performed using SPSS version 11 (SPSS
Inc., Chicago, IL, USA). Chi-squared and Fisher’s exact tests
were used for comparisons between categorical variables and
the t-test and Mann—Whitney U-test for comparisons
between continuous variables. Logistic regression analysis
was applied to indicate factors significantly associated with
the development of S. aureus infection. p-Values of 0.05 or
less were considered statistically significant.
Results
Outbreak characteristics
A review of themedical records revealed that the first case of
S. aureus infection occurred in November 2006. From Novem-
ber 1, 2006 through December 31, 2007, eight cases of S.
aureus infection were identified among HCWs, all concerning
practice nurses, giving a 10% attack rate among practice
nurses (8/81 practice nurses). All cases but one worked in
zone A. The attack rate among practice nurses from zone A
was 35% (7/20 practice nurses). Among the residents, only
one case was identified (attack rate 0.4%).
Infections were furuncles and small subcutaneous
abscesses located in the axilla or breast (six cases), lower
extremities (two cases), and face, abdomen, and upper
extremities (one case each). Full recovery was documented
in all cases. No complication or invasive S. aureus infection
occurred.
Microbiology
PVL-positive MRSA belonging to SCCmec type IV was isolated
from the lesions of the HCW with the active infection. S.
aureus nasal carriage was found in four (50%) of the cases, of
whom three (37.5%) were colonized by PVL-positive MRSA
SCCmec type IV and one by methicillin-susceptible S. aureus
(MSSA). In addition, S. aureus nasal carriage was found in 12
(33.3%) of the 36 controls, of whom only one was identified as
PVL-positive MRSA SCCmec type IV. Cases were more likely to
Figure 1 Distribution of cases in the practice nurses’ locker room.
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2.8%, p = 0.018).
Nasal S. aureus carriage was also detected in 16.7% of the
30 randomly screened residents. None of the screened resi-dents carried a PVL-positive MRSA strain. All environmental
cultures were negative for S. aureus.
PFGE revealed a common pattern for all MRSA isolates
tested. This pattern is the main PFGE pattern circulating in
e404 H.C. Maltezou et al.Greece, and similar to the PFGE pattern of the MLST80 strain
that appears to be spreading through Europe.9 All isolates
were susceptible to mupirocin.
Case—control study
In the univariate analysis (Table 1), factors associated with
the development of S. aureus infection were female gender,
profession of practice nurse, working in zone A, fewer work-
ing years in the same zone, direct contact with patients, poor
personal hygiene, and carriage of PVL-positive MRSA. At the
multivariate analysis level, only being a practice nurse and
working in zone A remained statistically significant risk fac-
tors for infection.
Hygiene inspection
Our visit to the LTCF revealed that alcohol-based antiseptic
was not available to HCWs. Most HCWs washed their handsTable 1 Case—control study of healthcare workers at the long-t
Characteristics Cases (%) (n
Female gender 8 (100)
Mean age, years (SD) 44.5 (8.7)
Mean BMI (SD) 27.9 (7.9)
Underlying disease 4 (50)
Profession
Practice nurse 8 (100)
Physician/nurse 0 (0)
Cleaner 0 (0)
Cook/waiter 0 (0)
Administration/technical 0 (0)
Mean duration in the facility, years 11.5
Department (zone)
A 7 (87.5)
B 0 (0)
C 1 (12.5)
D 0 (0)
Other 0 (0)
Mean duration in department, years 4.1
Direct contact with patients 8 (100)
Use of illegal IV drugs 0 (0)
Use of steroids 0 (0)
Antibiotics in the last 12 months 4 (50)
Hospitalization in the last 12 months 1 (12.5)
Admission to ICU in the last 12 months 0 (0)
Surgery in the last 12 months 2 (25)
Mean number of family members 3.5
Mean number of children in the family 1.5
Mean number of rooms in the house 3.3
S. aureus infection in family member 0 (0)
Good personal hygiene 2 (25)
Axilla shaving 7 (87.5)
Contact sports 0 (0)
Nasal S. aureus carriage 4 (50)
PVL-positive MRSA 3 (37.5)
MSSA 1 (12.5)
NS, not significant; SD, standard deviation; BMI, body mass index; IC
methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptwith plain soap. The distribution of the lockers within the
practice nurses locker room revealed two clusters (Figure 1).
Practice nurses often washed their underwear at the water
basins with plain soap in common use. Sharing clothes was
also a frequent practice among them.
Interventions
Hygiene education was conducted and written material on
MRSA, hand hygiene using antiseptics, and contact precau-
tions was distributed among HCWs. HCWs with active lesions
were advised to abstain from patient contact. Because of the
high MRSA carriage rate among HCWs and the potential of
further spread within the LTCF, intranasal mupirocin was
administered (twice daily for 5 days) concomitantly to all
HCWs and residents. Nasal swab cultures were repeated one
month later in 20 of 21 HCWs and residents who initially
tested positive. Persistent MSSA carriage was found in one
resident, thus the eradication rate for S. aureus was 95%.erm care facility
= 8) Controls (%) (n = 36) p-Value
22 (61.1) 0.041
46.5 (10.9) NS
25.9 (3.3) NS
7 (19.4) NS
9 (25) 0.04
5 (13.9)
6 (16.7)
9 (25)
7 (19.4)
24 NS
5 (13.9) 0.01
5 (13.9)
7 (19.4)
6 (16.7)
13 (36.1)
9.6 0.013
21 (58.3) 0.037
0 (0) NS
2 (5.6) NS
16 (44.4) NS
4 (11.1) NS
1 (2.8) NS
2 (5.6) NS
2.8 NS
1.2 NS
2.9 NS
1 (2.8) NS
28 (77.8) 0.008
20 (55.6) 0.125
6 (16.7) NS
12 (33.3) NS
1 (2.8) 0.018
11 (30.6)
U, intensive care unit; PVL, Panton—Valentine leukocidin; MRSA,
ible Staphylococcus aureus.
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infection had been reported among either HCWs or residents.
Discussion
Outbreaks of PVL-positive CA-MRSA in LTCFs have been
reported only scantily, with carriage rates of up to 9.7%
reported among residents and HCWs.21—23 To our knowledge,
this is the first reported outbreak of PVL-positive MRSA strains
in a healthcare facility involving exclusively HCWs. No MRSA
carriage was traced in the residents and this may be attrib-
uted to their higher age compared with HCWs, as found in
other studies.24 We did not screen HCW hands and resident
groin areas, thus it is possible that a few carriers were
missed.21,25
The causative strain was most probably introduced from
the community into the LTCF through a colonized practice
nurse who subsequently spread it directly to her colleagues.
Poor personal hygiene among practice nurses was documen-
ted. The fact that cases were more likely to carry PVL-
positive MRSA strains than controls is consistent with the
association of CA-MRSA carriage with the development of skin
and soft tissue infections. PVL is a toxin that acts through
leukocyte destruction and mediation of tissue necrosis, and
has been associated with skin and soft tissue infections, but
occasionally with severe necrotizing pneumonia and invasive
infections.1,26
Unrecognized PVL-positive MRSA carriers among HCWs
may represent an important reservoir for infection. Once a
PVL-positive MRSA strain is introduced into a healthcare
facility, it may be transmitted nosocomially. In a recent
outbreak that involved nine healthy children with severe
infections caused by PVL-producing CA-MRSA strains includ-
ing one lethal case, the infection was transmitted by an
asymptomatic colonized HCW during vaccination.27 Admis-
sion of unrecognized carriers, prolonged asymptomatic colo-
nization, inadequate laboratory identification, and poor
adherence to hand hygiene measures may facilitate the
spread of PVL-positive MRSA within hospitals.1
The sustained elimination of MRSA carriage within a
healthcare facility may prove difficult and take several
courses.28 A recent meta-analysis concluded that there is
insufficient evidence to support topical or systemic therapy
for eradicating MRSA carriage.29 In the current outbreak, our
decision for blanket decolonization of all residents and staff
with mupirocin could be regarded as excessive, especially
given the paucity of evidence of transmission other than
between practice nurses, the absence of severe disease,
and no evidence of onward transmission to residents. How-
ever it appears that mupirocin, in association with infection
control measures, was effective for PVL-positive MRSA and
MSSA eradication. Similar to our results, the total MRSA
prevalence decreased from 11.3% to 5.5% and PVL-positive
MRSA prevalence from 9.1% to 3.3% following treatment with
mupirocin in a healthcare associated PVL-positive MRSA out-
break in Germany.21 We suggest that intranasal mupirocin
should be considered in order to contain MRSA outbreaks
within closed settings, in association with infection control
measures.
In conclusion, our results indicate that HCWs may serve as
vehicles for the entry of such strains from the community, and
that deficient hygiene practices and unrecognized carriagemay facilitate spread. Given the increasing prevalence of
PVL-positive MRSA infections worldwide, guidelines for the
eradication of PVL-positive MRSA carriage within HCWs in
closed communities should be established and efforts to
obtain cultures from compatible infections should be made.
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